• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Essilor breaks ground on new corporate campus

Article

Farmers Branch, TX-Corporate, state, and local officialsjoined together recently to break ground on Essilor of America'snew U.S. corporate campus. Development of the campus is planned asa 5-year process. Phase one will redevelop existing structures andconstruct new buildings to create 270,000 square feet of space.

Farmers Branch, TX-Corporate, state, and local officials joined together recently to break ground on Essilor of America's new U.S. corporate campus. Development of the campus is planned as a 5-year process. Phase one will redevelop existing structures and construct new buildings to create 270,000 square feet of space.

Pictured during the groundbreaking event are (from left): Linda Burns, Greater Dallas Chamber of Commerce; Linda Groomer, city manager, Farmers Branch; Charlie Bird, mayor pro tem, Farmers Branch; Junie Smith, council member, Farmers Branch; Bob Phelps, mayor, Farmers Branch; and Laurent Vacherot, president, Essilor of America.

Related Videos
John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting
What keeps you up at night in ophthalmology: Part II
Chris Adams, Diopter Corp CEO
Ramin Valian, of Allergan, discusses pharmaceuticals in the glaucoma industry at Glaucoma 360
© 2024 MJH Life Sciences

All rights reserved.